The pandemic's impact on non-COVID research
Non-COVID-19 research has taken a back seat during the pandemic as scientists everywhere scramble to better understand the Sars-CoV-2 virus and develop therapies and vaccines. But it remains important for the scientific community to strongly advocate for sustained investment into non-COVID research. Share your experiences and perspectives to help inform our policy solutions to sustain non-COVID-19 research.
Speakers
David Kennedy
Vice president and director of costing policies, Council on Governmental Relations
Melur K. Ramasubramanian
Vice president for research, University of Virginia
Nick Rhind
Professor, University Massachusetts Medical School
Who should watch
- Researchers focused on non-COVID research
- Heads of labs
Learning objectives
Understand the experience of shutting down and ramping up non-COVID research, funding for non-COVID research, challenges and obstacles to restarting non-COVID research.